ALEXANDRA MCMULLAN: Open Payments
NPI 1255870218 · FLOWER MOUND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,669 in 162 payments from 22 companies in 2025. Trend: 2023 $1,374 · 2024 $2,430 · 2025 $2,669
Food & beverage: $2,603Education: $66
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 12 | $378 |
| Arcutis Biotherapeutics, Inc. | 19 | $325 |
| Janssen Biotech, Inc. | 16 | $287 |
| UCB, Inc. | 13 | $204 |
| MAYNE PHARMA COMMERCIAL LLC | 23 | $197 |
| Galderma Laboratories, L.P. | 15 | $195 |
| ABBVIE INC. | 16 | $192 |
| Amgen Inc. | 13 | $146 |
| Regeneron Healthcare Solutions, Inc. | 6 | $146 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $82 |
Products named: OPZELURA, Zoryve, TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, OTEZLA, NEMLUVIO.
Industry payments across TX — which companies pay providers there.
